Procleix HEV Assay (CE Marked)
Single-tube, highly sensitive detection of the hepatitis E virus RNA in blood and plasma donations.
The Procleix HEV assay is CE marked. This assay is not available for commercial sale in the US.
Assay Performance Characteristics*
Assay chemistry
- Procleix Panther system
- 
                                                                Qualitative, transcription-mediated amplification (TMA) 
Indication
- Procleix Panther system
- 
                                                                Blood screening, source plasma, cadaveric (non-heart-beating) donors 
Collection tube
- Procleix Panther system
- 
                                                                Serum or plasma from EDTA, ACD, heparin or sodium citrate anti-coagulated samples 
Pool sizes
- Procleix Panther system
- 
                                                                ID-NAT, 4, 8, 16 
Assay kit size
- Procleix Panther system
- 
                                                                1000 or 5000 tests 
Detected virus
- Procleix Panther system
- 
                                                                HEV (genotypes 1-4)*** 
| Platform | Procleix Panther system | 
|---|---|
| Assay chemistry | Qualitative, transcription-mediated amplification (TMA) | 
| Indication | Blood screening, source plasma, cadaveric (non-heart-beating) donors | 
| Collection tube | Serum or plasma from EDTA, ACD, heparin or sodium citrate anti-coagulated samples | 
| Pool sizes | ID-NAT, 4, 8, 16 | 
| Assay kit size | 1000 or 5000 tests | 
| Detected virus | HEV (genotypes 1-4)*** | 
Specificity in Fresh and Frozen Normal Blood Donor Plasma Specimens
4494
- Specificity %
- 
                                                                99.98 
- 95% confidence interval
- 
                                                                99.87 - 100 
| # of samples | Specificity % | 95% confidence interval | 
|---|---|---|
| 4494 | 99.98 | 99.87 - 100 | 
Analytical Sensitivity
Detection Probability (IU/mL)
HEV WHO international standard**
- 50% (95% fiducial limits)
- 
                                                                2.02 (1.71 - 2.32) 
- 95% (95% fiducial limits)
- 
                                                                7.89 (6.63 - 9.83) 
| Panel Tested | 50% (95% fiducial limits) | 95% (95% fiducial limits) | 
|---|---|---|
| HEV WHO international standard** | 2.02 (1.71 - 2.32) | 7.89 (6.63 - 9.83) | 
Explore other Procleix Assays
Expand your blood screening with a comprehensive NAT assay portfolio.